{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:23Z","timestamp":1791655403966,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020534","name":"Alcon Japan Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004286","name":"Santen Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["24K12810"],"award-info":[{"award-number":["24K12810"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["23K19674"],"award-info":[{"award-number":["23K19674"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xops.2026.101317","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:35:10Z","timestamp":1783352110000},"page":"101317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-Dimensional Vitreous Proteomics Identifies Epigenetic Pathway Signatures in Vitreoretinal Lymphoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Jun","family":"Funatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyo","family":"Yawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0272-0075","authenticated-orcid":false,"given":"Yuki","family":"Asahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunobu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xops.2026.101317_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09273940903168696","article-title":"Pathophysiology of retinal lymphoma","volume":"17","author":"Coupland","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101317_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10384-025-01310-3","article-title":"Recent advances in the diagnosis and treatment of refractory ocular inflammatory diseases: focus on uveitic macular edema, acute retinal necrosis, and vitreoretinal lymphoma","volume":"70","author":"Takeda","year":"2025","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.xops.2026.101317_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10384-012-0150-7","article-title":"Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma","volume":"56","author":"Kimura","year":"2012","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2026.101317_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2013.12.001","article-title":"Primary intraocular lymphoma","volume":"59","author":"Sagoo","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"81","key":"10.1016\/j.xops.2026.101317_bib5","first-page":"93","article-title":"Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma","volume":"15","author":"Chan","year":"2013","journal-title":"Discov Med"},{"key":"10.1016\/j.xops.2026.101317_bib6","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/09273948.2021.1873394","article-title":"More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic Test results: a prospective observational Study","volume":"30","author":"Tanaka","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.xops.2026.101317_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030598","article-title":"Diagnosing vitreoretinal Lymphomas-An analysis of the sensitivity of existing tools","volume":"14","author":"Sehgal","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xops.2026.101317_bib8","doi-asserted-by":"crossref","DOI":"10.18502\/jovr.v20.17181","article-title":"Intraocular lymphoma: a review","volume":"20","author":"Karimi","year":"2025","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.xops.2026.101317_bib9","article-title":"Cytologic and molecular diagnostics for vitreoretinal lymphoma: current approaches and emerging single-cell analyses","volume":"7","author":"Tan","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10.1016\/j.xops.2026.101317_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.survophthal.2023.12.001","article-title":"Diagnostic methods for primary vitreoretinal lymphoma: a systematic review","volume":"69","author":"Huang","year":"2024","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2026.101317_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052385","article-title":"Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis","volume":"8","author":"Fisson","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.xops.2026.101317_bib12","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1167\/iovs.15-17465","article-title":"Distinct profiles of soluble cytokine receptors between B-Cell vitreoretinal lymphoma and uveitis","volume":"56","author":"Takeda","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.xops.2026.101317_bib13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/aos.14036","article-title":"Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma","volume":"97","author":"de Hoog","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101317_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72962-z","article-title":"Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma","volume":"10","author":"Takeda","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xops.2026.101317_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065627","article-title":"Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma","volume":"8","author":"Raja","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xops.2026.101317_bib16","article-title":"Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.xops.2026.101317_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.64.15.2","article-title":"Vitreous humor proteomic profile in patients with vitreoretinal lymphoma","volume":"64","author":"Komatsu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.xops.2026.101317_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1167\/iovs.66.3.38","article-title":"An approach to predict intraocular diseases by machine learning based on vitreous humor immune mediator profile","volume":"66","author":"Sugawara","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.xops.2026.101317_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbt.2011.11.016","article-title":"Advances in human proteomics at high scale with the SOMAscan proteomics platform","volume":"29","author":"Gold","year":"2012","journal-title":"N Biotechnol"},{"issue":"12","key":"10.1016\/j.xops.2026.101317_bib20","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1021\/acs.jproteome.4c00667","article-title":"Variability of 7K and 11K SomaScan plasma proteomics assays","volume":"23","author":"Candia","year":"2024","journal-title":"J Proteome Res"},{"issue":"22","key":"10.1016\/j.xops.2026.101317_bib21","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1016\/j.cell.2023.09.012","article-title":"Liquid-biopsy proteomics combined with AI identifies cellular drivers of eye aging and disease in vivo","volume":"186","author":"Wolf","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.xops.2026.101317_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"7360","key":"10.1016\/j.xops.2026.101317_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in Non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.xops.2026.101317_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.xops.2026.101317_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"17","key":"10.1016\/j.xops.2026.101317_bib26","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","article-title":"Genome-Wide analysis uncovers novel recurrent alterations in primary central nervous System lymphomas","volume":"21","author":"Braggio","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.xops.2026.101317_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xops.2026.101317_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.xops.2026.101317_bib29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-Cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"7337","key":"10.1016\/j.xops.2026.101317_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.xops.2026.101317_bib31","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1182\/blood-2010-05-285320","article-title":"DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma","volume":"116","author":"Shaknovich","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.xops.2026.101317_bib32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2013-07-509885","article-title":"Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes","volume":"123","author":"Chambwe","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.xops.2026.101317_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"7761","key":"10.1016\/j.xops.2026.101317_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.xops.2026.101317_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ccell.2019.09.003","article-title":"Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA","volume":"36","author":"van der Pol","year":"2019","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.xops.2026.101317_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.xops.2026.101317_bib37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00401-011-0891-2","article-title":"Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma","volume":"122","author":"Montesinos-Rongen","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.xops.2026.101317_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1350-9462(99)00016-6","article-title":"Structural macromolecules and supramolecular organisation of the vitreous gel","volume":"19","author":"Bishop","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.xops.2026.101317_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.xops.2026.101317_bib40","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/nprot.2017.054","article-title":"Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry","volume":"12","author":"Keshishian","year":"2017","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.xops.2026.101317_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.xops.2026.101317_bib42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:21:37Z","timestamp":1789464097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666914526002551"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101317","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dimensional Vitreous Proteomics Identifies Epigenetic Pathway Signatures in Vitreoretinal Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101317"}}